Composition
- Active ingredients
- ALPELISIB 200MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ALPELISIB 150MG · TabletNDA212526-002 · Prescription
- ALPELISIB 200MG · TabletThis page
- ALPELISIB 50MG · TabletNDA212526-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA212526.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Piqray
- Active substance
- alpelisib
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Novartis
- Status
- Prescription
- FDA approval
- 24 May 2019
- Application
- NDA212526-003